Cargando…
Adiponectin: An Indicator for Metabolic Syndrome
BACKGROUND: Metabolic syndrome (MetS), a cluster of cardiometabolic risk factors, consider as a manifestation of obesity. However, a proportion of obese patients do not develop MetS. The aim of our study was to determine whether concentration of plasma adiponectin and leptin differ between metabolic...
Autores principales: | YOSAEE, Somaye, KHODADOST, Mahmoud, ESTEGHAMATI, Alireza, SPEAKMAN, John R., DJAFARIAN, Kurosh, BITARAFAN, Vida, SHIDFAR, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635323/ https://www.ncbi.nlm.nih.gov/pubmed/31341853 |
Ejemplares similares
-
Serum irisin levels in metabolically healthy versus metabolically unhealthy obesity: A case-control study
por: Yosaee, Somaye, et al.
Publicado: (2020) -
Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals
por: Bitarafan, Vida, et al.
Publicado: (2019) -
Depressive symptoms among metabolically healthy and unhealthy overweight/obese individuals: a comparative study
por: Yosaee, Somaye, et al.
Publicado: (2018) -
Diet quality in obese/overweight individuals with/without metabolic syndrome compared to normal weight controls
por: Yosaee, Somaye, et al.
Publicado: (2016) -
Association between dietary inflammatory index and components of metabolic syndrome
por: Ghorabi, Sima, et al.
Publicado: (2020)